Breaks Categories: Stock Spotlights

MondayJul 03, 2023 12:10 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-Processed Formulation Results in Higher Concentration, Delivery of Estrogen Hormone than Control

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently completed its animal study HOR-A22-1, which showed that the company’s patented DehydraTECH(TM) technology platform significantly enhanced the oral delivery of the estrogen hormone estradiol. “The study found that the DehydraTECH-estradiol composition resulted in a maximum concentration in the bloodstream (‘Cmax’) of 5.65 ng/mL, which was approximately 900% higher than the control formulation’s Cmax (0.63 ng/mL). Additionally, the use of the DehydraTECH-formulation resulted in a 2,000% increase in the levels of the estrone metabolite, also measured using the Cmax parameter: DehydraTECH-estradiol resulted in a Cmax of 6.49 ng/mL…

Continue Reading

MondayJul 03, 2023 11:37 am

NetworkNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Adds Greater Flexibility, Accelerated Technology Development Capability to NVIDIA Omniverse Platform

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, recently integrated its Vista-X120 Plus lidar into DRIVE Sim, an end-to-end simulation application built on the NVIDIA Omniverse platform. “The NVIDIA Omniverse platform enables real-time simulation and 3D visualization for metaverse applications by providing a shared virtual environment where users can collaborate to engineer real-world scenarios… Cepton was one of the first companies to demonstrate a 360°-coverage, dual-range lidar simulation that detected long-range obstacles and eliminated near-range blind spots. The addition of the Vista-X120 Plus into the Omniverse builds upon previous integrations to give AV developers access…

Continue Reading

MondayJul 03, 2023 11:34 am

NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Well Positioned to Move next NanoAb Candidates into Clinical Application

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, recently signed an exclusive worldwide license agreement to develop and commercialize VHH antibodies (“NanoAbs”) that target Interleukin-17 (“IL-17”). “The license agreement is part of a broad-based collaboration with the Max Planck Society and the University Medical Center Göttingen (‘UMG’). The NanoAbs will be targeted toward the treatment of several relevant indications, including, but not limited to, psoriasis and psoriatic arthritis. BiondVax’s collaboration with the Max Planck Institute for Multidisciplinary Sciences and UMG, both based in Germany,…

Continue Reading

MondayJul 03, 2023 11:24 am

NetworkNewsBreaks – GolfLync Inc. Affirms Status as Go-to ‘Social Network for Golfers’

GolfLync is the company behind the GolfLync app – a social network for matching golf games and players. “GolfLync just affirmed its status as the go-to ‘social network for golfers’ with over 200 5-star ratings on the Apple App Store. The ratings reflect the warm reception the app has received thus far, the level of thoughtfulness and detail that went into its development, and the real user value that GolfLync delivers to the growing community of golf enthusiasts around the country. Ratings are the way users find the top apps in a category, and GolfLync is significantly higher than the…

Continue Reading

TuesdayJun 20, 2023 3:36 pm

NetworkNewsBreaks – Starco Brands, Inc.’s (STCB) Whipshots Surpasses 2M Cans Sold

Starco Brands (OTCQB: STCB), a modern-day ‘invention factory’ that invents or acquires novel products and advances them using behavior-changing technologies, recently launched Lime Whipshots, its latest addition to its vodka-infused whipped cream product line featuring global icon Cardi B. “Whipshots Lime joins other flavors in the product line, including vanilla, caramel and mocha – all infused with a 10% premium vodka kick. Starco Brands launched the product in December 2021, achieved its first million can sales after ten months and sold another million cans only four months later. Whipshots has also gained widespread industry recognition with several awards, including the…

Continue Reading

FridayJun 16, 2023 3:03 pm

NetworkNewsBreaks – SideChannel Inc. (SDCH) Offering Top-Tier Security Guidance at a Manageable Cost

SideChannel (OTCQB: SDCH) is committed to helping small and medium-sized businesses (“SMBs”) that are otherwise susceptible to new cybersecurity threats due to their limited resources for investing in cybersecurity systems, services and infrastructure. “As a company founded on the belief that all enterprises, big or small, deserve top-tier security guidance at a manageable cost, SideChannel is aware of how technically demanding current cybersecurity solutions are, particularly when factoring in the possibility of AI. In addition, it recognizes how involved these solutions can be and how these two aspects leave SMBs vulnerable to attacks. Through its team of virtual Chief Information…

Continue Reading

FridayJun 16, 2023 2:43 pm

NetworkNewsBreaks – GolfLync Inc. Tapping into Growing Industry Momentum with One-of-a-Kind App

GolfLync, the company behind the GolfLync app – a social network for matching games and players, recently hit an incredible milestone of 17,000 downloads as of May 2023. “Dubbed ‘the social network for golfers,’ GolfLync is committed to helping golfers looking to grow their network by offering a platform that opens them up to other players with similar interests and course preferences. The growth in app downloads indicates golf’s growing popularity, especially in the United States. Since 2011, the United States golf industry has grown by 22% over the past 10 years, from $68.8 billion to $84 billion in 2023.…

Continue Reading

FridayJun 16, 2023 2:27 pm

NetworkNewsBreaks – Genprex Inc.’s (NASDAQ: GNPX) Flagship Candidate Could Potentially Reshape NSCLC Landscape

Genprex (NASDAQ: GNPX) is conducting its Phase 1/2 Acclaim-1 clinical trial evaluating the safety and efficacy of combining REQORSA(R), the company’s innovative drug candidate, in combination with Tagrisso(R) in patients with advanced EGFR mutant non-small cell lung cancer (“NSCLC”) who have experienced disease progression after previous treatments. “REQORSA Immunogene Therapy represents a potentially groundbreaking experimental drug that harnesses the power of genetic medicine to combat NSCLC,” a recent article explains. “During the Phase 1 portion of the clinical trial, the primary emphasis is on evaluating the safety of the treatment. However, the findings also have revealed promising efficacy results. One…

Continue Reading

FridayJun 16, 2023 2:14 pm

NetworkNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Accelerates Efforts to Establish North American REE Supply Chain

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a critical metals production innovator, is accelerating its efforts to establish a North American-focused supply chain for rare earth elements (“REEs”). The company announced in April that it had reached an agreement to lease an 80,800 square-foot brownfield facility in Alexandria, Louisiana, for its first Strategic Metals Complex (‘SMC’) facility for REE separation and oxide production. “The company has strengthened its financial position and is working to fulfill plans to launch construction of the Louisiana SMC this year, building to a production capacity of 2,000 metric tons of total rare earth oxides in…

Continue Reading

FridayJun 16, 2023 1:59 pm

NetworkNewsBreaks – Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Committed to Supporting Fintech, Digital Money Processes in Underserved Markets

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) continues to move forward with plans to offer a diverse portfolio of fintech-related products and services for consumers and businesses throughout the global financial ecosystem. “Digital money is replacing physical cash, with consumers able to buy products and services anywhere in the world and make payments across borders. FEXD is developing mobile transaction platforms and services that are helping implement the coming changes – especially in underserved and overlooked markets like rural areas and Asia, the Middle East, Africa, and Latin America. FEXD supports the United Nations’ Sustainable Development Goal to reduce cross-border transaction…

Continue Reading